Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS In Brief

This article was originally published in The Gray Sheet

Executive Summary

MedCAC posts meeting questions: CMS has 1posted a list of voting questions for the Medicare Evidence Development and Coverage Advisory Committee to address during its Sept. 22 meeting on evidence for on- and off-label use of bone morphogenetic proteins. CMS wants feedback on MedCAC's level of confidence that FDA-approved uses of BMPs can improve outcomes related to the lumbar spine, open tibia fractures and recalcitrant long bone nonunion and that off-label use can improve outcomes in the cervical spine, the lumbar spine or elsewhere. The panel will review evidence on BMP products from Medtronic and Stryker. On July 27, an FDA advisory panel had a mixed response to Medtronic's Amplify rhBMP-2 Matrix spinal treatment, currently under PMA review for posterolateral spine fusion
Advertisement

Related Content

CMS Revisits Coverage Policy For MRI In Patients With Cardiac Implants
Medtronic Hopes For Speedy U.S. Launch Of Revo MRI-Friendly Pacer
CMS Will Cover Warfarin Gene Tests In Clinical Trials, But That's It
CMS Will Cover Warfarin Gene Tests In Clinical Trials, But That's It

Topics

Advertisement
UsernamePublicRestriction

Register

MT029190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel